RxDoctor Payments Data

Jeremy Lough, MD

Otolaryngology · Reno, NVNPI 1275643306

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,893 of the $4,060 with a category attached, or 71.2%. Inspire Medical Systems, Inc. accounts for 73.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $1,930 and has fallen 81.6% since, to $355 in 2025.

$4,060in general payments, 2019–2025

Across 60 payments — averaging $67.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$3K
  • Optinose US, Inc.$323
  • Stryker$195
  • Shire North American Group Inc$113
  • Acclarent, Inc$82
  • Intersect ENT, Inc.$67
  • plus $292 from 11 others

What the payments were for

  • Travel & lodging$1,16729%
  • Food & beverage$2,89371%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,060 in reported general payments places this provider in the 65th percentile of 41 otolaryngology providers in Nevada.

See all otolaryngology providers in Nevada

Medicare billing

Part B allowed, 2024
$132,030
Medicare patients
389
Services billed
866

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin42$3,907
Ipratropium Bromide98$3,687
Prednisolone Acetate19$1,393
Fluticasone Propionate48$996
Duloxetine Hcl54$849
Gabapentin27$653
Triamcinolone Acetonide17$524
Cefdinir27$502
Lurasidone Hcl27$461
Nifedipine ErNifedipine27$433
Carvedilol27$366
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen67$350
Atorvastatin Calcium27$310
Methylprednisolone37$270
Trazodone Hcl13$160

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →